v3.26.1
Condensed Unaudited Consolidated Statements of Cash Flow - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,248,861) $ (4,216,707)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of Deferred Grant Reimbursement (23,983) (27,158)
Depreciation of property and equipment 151,096 142,759
Change in fair value of derivative instruments (172,859)
Non-cash lease expense (7,854) 14,629
Stock-based compensation 1,720,037 884,531
Changes in operating assets and liabilities:    
Grants receivable 316,103 479,875
Due from related party (18,616)
Prepaid expenses and other current assets 86,659 76,371
Accounts payable and accrued expenses 38,889 6,377
Due to related party (5,330) (32,209)
Net cash (used in) operating activities (3,164,719) (2,671,532)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Deferred grant reimbursement 19,699
Purchases of property and equipment (57,603) (81,619)
Net cash provided by (used in) investing activities (57,603) (61,920)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from issuance of common stock and warrants 5,861,147
Payments on finance lease obligations (25,472)
Net cash provided by financing activities 5,835,675
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS 2,613,353 (2,733,452)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 3,039,343 9,719,310
CASH AND CASH EQUIVALENTS - END OF PERIOD 5,652,696 6,985,858
Supplemental disclosures of cash flow information:    
Interest Expense 3,759 1,693
Non-cash investing and financing activities:    
Forgiveness of debt $ 147,103